Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 11Gynecologic 2Gastrointestinal 1

Conditions

Ovarian Neoplasms 178Endometrial Neoplasms 110Uterine Cervical Neoplasms 100Breast Neoplasms 58Colorectal Neoplasms 49Fallopian Tube Neoplasms 45Carcinoma, Non-Small-Cell Lung 42Neoplasms 36Pancreatic Neoplasms 34Prostatic Neoplasms 27Neoplasm Metastasis 27Stomach Neoplasms 25Melanoma 25Squamous Cell Carcinoma of Head and Neck 22Lung Neoplasms 22Esophageal Neoplasms 21Carcinoma, Ovarian Epithelial 20Triple Negative Breast Neoplasms 19Carcinoma, Renal Cell 18Urinary Bladder Neoplasms 17Head and Neck Neoplasms 17Colonic Neoplasms 16Carcinoma, Transitional Cell 16Carcinoma, Hepatocellular 15Small Cell Lung Carcinoma 14Sarcoma 14Cholangiocarcinoma 14Uterine Neoplasms 13Vulvar Neoplasms 12Rectal Neoplasms 12

Interventions

pembrolizumab 1Carboplatin 1Bevacizumab 1AZD5305 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Adenocarcinoma of Lung × Gynecologic × 30 days × Clear all
NCT05797168 2026-06-03

FONTANA

AstraZeneca

Phase 1/2 Recruiting
506 enrolled
GynecologicThoracic

Adenocarcinoma of Lung, Ovarian Neoplasms, Endometrial Neoplasms

NCT06843629 2026-05-28

Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Recruiting
100 enrolled
GastrointestinalGynecologicThoracic

Adenocarcinoma of Lung, Ovarian Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡